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ABSTRACT 
 The clean catch urine collection method was originally developed in the 1950’s, during a 
time when urine was considered sterile (Thomas-White et al., 2016). Its development replaced the 
invasive catheter urine collection method and allowed for what was thought to be a urine sample 
without genital contamination. However, since its development over half a century ago (Smythe 
et al., 1960; Thomas-White et al., 2016), more sensitive assays have been advanced for culturing 
urinary bacteria (Hilt et al., 2014), whereas the clean catch method itself has remained unchanged. 
These new assays, which culture a higher percentage of bacteria present, have shown clean catch 
is not as clean as once speculated and actually contains high levels of vulvo-vaginal contamination. 
In light of these more sensitive assays, I reassessed the clean catch method, endeavoring to 
optimize this method while recording various lifestyle factors. Periurethral swabs and voided 
urines were routinely collected, while analyzing different aspects of the clean catch method, such 
as type of void, time of void, and use of antiseptic wipes prior to void. I determined that midstream 
urine contained the least amount of vulvo-vaginal contamination and that the time of collection 
did not impact the results. I also determined that the use of antiseptic wipes prior to void increased 
the level of vulvo-vaginal contamination.  
Since a urine collection method that could be used daily did not exist, the stability of the 
genitourinary tract in healthy females had remained unknown. In contrast, others had studied the 
microbial stability of other body sites, such as the gastrointestinal tract (GIT) and the vagina, and 
found that the microbiota varied very little over short time intervals (Aagaard et al., 2013; Faith
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et al., 2013; “The Human Microbiome Project Consortium”, 2012). To begin to fill this knowledge 
gap, I performed a longitudinal study, using a modified version of the enhanced quantitative 
culture technique (MEQUC) to follow the microbiota of the lower urinary tract (LUT) and 
periurethra (the genitourinary microbiome or GUM) of one female over the course of 7 months. I 
noted that both the voided urine and periurethra contained very distinct microbial niches and that 
they remained relatively stable over the course of the 7-month period. Using the recorded life style 
factors data, I noticed that alcohol may have an effect on the LUT microbiome of one female and 
that the LUT microbiome appeared to be resilient, returning to baseline levels within a few days. 
I recruited 8 female participants and assessed the stability of the GUM pre- and post-alcohol 
consumption. These females collected daily periurethral swabs and midstream voids over a 17-day 
period and kept a strict alcohol diary including amount of alcohol consumed, types of alcohol 
consumed, and length of alcohol consumption. The microbial and chemical composition of these 
specimens were compared and showed an acute drop in urinary Lactobacillus following binge 
drinking. It was hypothesized that this drop in Lactobacillus was due to an increase in alcohol 
metabolites in the urine. In order to determine whether alcohol metabolites played a role, I 
measured ethanol, acetaldehyde, and acetate in urine pre- and post- alcohol consumption. I then 
subjected urinary isolates collected pre- and post-alcohol consumption to sensitivity assays 
containing these alcohol by-products at the levels detected. I found that the concentration of 
alcohol metabolites found in the urine did not inhibit bacterial growth and was not a direct factor 
for the acute drop in urinary Lactobacillus. During this study, one participant developed a urinary 
tract infection (UTI), which I was able to detect prior to patient’s self-reported symptoms. E. coli 
was determined to be the causative agent of infection and the levels of acetaldehyde found in the 
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urine during the final stages of the UTI were high enough to inhibit growth of Lactobacillus. This 
may suggest a potential mechanism of virulence associated with E. coli during UTI.  
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CHAPTER I 
INTRODUCTION 
Every Ecosystem on Earth Contains Living Microbes – Why Not the Bladder? 
Microbial diversity is quite unique and microbes thrive in all parts of the planet. These microbial 
populations are vital to all ecosystems of the earth, and the human body should not be overlooked. 
The human microbiome project, started in 2008, sought to map the microbial diversity found 
within the human body and began by mapping the microbial communities present in the oral cavity, 
nares, skin, gastrointestinal tract, and vagina (“The Human Microbiome Project Consortium”, 
2012). However, due to the clinical dogma that urine is sterile, the bladder was overlooked. 
Consequently, there is little knowledge about this unique niche and the microbiota that reside there.  
 In standard clinical practice, 1uL of urine is spread onto both blood agar plates (BAP) and 
MacConkey agar plates, and incubated aerobically for 24 hours. Often, following this procedure, 
the plates do not contain bacterial colonies or contain colonies that resemble vulvo-vaginal 
organisms that are thought to be contaminants. Thus, the clinical microbiologist reports “no 
growth.” The use of the term “no growth” has fueled the clinical dogma that urine is sterile. First, 
“no growth” does not mean “no bacteria,” but instead “no uropathogens.” Second, many microbes 
do not thrive under the conditions of the standard urine culture test. Therefore, the Loyola Urinary 
Education and Research Collaborative (LUEREC) predicted that bacteria may 
!
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thrive in the bladder, but are not detected by the standard culture method. Using the polymerase 
chain reaction and deep 16S rRNA gene sequencing, LUEREC identified bacterial DNA from 
catheterized urine samples which were deemed “no growth” by standard urine culture (Wolfe et 
al., 2012). This raised the question: why were the standard cultures negative? A survey of the 
sequenced genera revealed bacteria that could not grow under the standard conditions. It was 
determined that if growth conditions were modified, then the sequenced bacteria would be able to 
grow. Thus, the Enhanced Quantitative Urine Culture (EQUC) protocol was developed. This new 
technique revealed live cultivable bacteria in urine collected by transurethral catheterization from 
women with symptoms of urinary urgency incontinence and from asymptomatic controls (Hilt et 
al., 2014). The discovery of live bacteria in the bladders of women with negative (no growth) 
standard urine cultures raises many questions, but especially which bacteria contribute to good 
health and which contribute to disease. Understanding the microbial diversity in healthy 
individuals and the conditions that allow the proper diversity to thrive may assist us in visualizing 
and interpreting microbial dysbiosis of diseased states. 
Human Microbiome Stability and Disease 
Several research groups have investigated the longitudinal stability of various body sites of both 
symptomatic and asymptomatic individuals, and dysbiosis of these communities has been 
associated with various disease states (Engen et al., 2015; Gajer et al., 2012; Galloway-Peña et 
al., 2017; Mutlu et al., 2012). In one study, an individual’s gastrointestinal tract (GIT) and salivary 
microbiomes were followed over the course of one year. The researchers found that these microbial 
communities were relatively stable and that various factors could alter the stability for short time 
periods, but that they were resilient and returned to their baseline states (David et al., 2016). 
!
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Another study, following hospitalized cancer patients with acute myeloid leukemia, found 
longitudinal instability of both the GIT and oral microbiome (Galloway-Peña et al., 2017), which 
suggests there may be interplay between bacterial communities and human health. 
 Research has revealed distinct differences in the microbiota of the female urinary bladder 
(termed the Female Urinary Microbiota or FUM) between populations of individuals with lower 
urinary tract symptoms (LUTS), such as those associated with urinary tract infection (UTI) or 
urgency urinary incontinence (UUI), and individuals without LUTS (Pearce et al., 2014; Pearce et 
al., 2016). However, these seminal studies were performed at a single time point and there are no 
studies investigating the longitudinal FUM stability, in part due to the clinical dogma that urine is 
sterile. In order to better understand urinary health, it is imperative that we fill this gap. 
Associations between healthy and diseased states may be the missing links to improving overall 
treatment and outcomes of women and men with urinary tract disorders. 
Measuring Species Diversity of Microbial Communities 
One fundamental feature of microbial communities is diversity. Species diversity of a community 
is the variety of organisms that make up the community and it is composed of two components: 
richness, which is the number of different species in the community, and evenness, a measure of 
distribution that takes into account the proportion of each species within the community. Figure 1 
provides an example. In this figure, there are two trees. The question is: which tree has greater 
biodiversity or a greater variety of life forms? In tree 1, there are 4 different kinds of birds and in 
tree 2 there are also 4 different kinds of birds. This makes their species richness the same. However, 
tree 1 is more diverse because each species is represented an equal amount of times, whereas in 
tree 2, one species of bird is much more common than the others making tree 2 less diverse. This 
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difference in diversity is due to species evenness. To determine species evenness, the number of 
individuals in each species is counted to determine relative abundance or how common each 
species is. In tree 1, there are 4 species (A, B, C, and D). If we count the number of individual 
species, we find that each species represents 25% of the total number of individuals in the 
community. Since all of the species are represented equally, this community has high evenness. In 
contrast, tree 2 has one species that is much more common than all the rest. Since species “A” 
represents 75% of individuals, tree B has low evenness. 
 
Community A    Community B 
A: 25% B: 25% C: 25% D:25%  A: 75% B: 8.3% C: 8.3% D: 8.3% 
 
Figure 1. Avian Species Diversity of a Tree 
 Several different indices have been developed that measure richness and/or evenness, 
providing the researcher with a single number that can be used to compare diversity among 
communities. The Shannon diversity index measures species richness or how many unique species 
are found in a community. However, the values of this index are non-linear and are merely the 
!
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value of the index, not the real diversity and thus it contains no units. One way to obtain a measure 
of true diversity is to convert the index to the effective numbers of species (ENS). This gives the 
values a common property and is always measured as number of species. The Simpson’s Index is 
a measure of the chance that two randomly selected microorganisms are of the same species and 
thus it is a measure of evenness. Again, these values are non-linear and are merely the value of the 
index, but these values can be used to compare compare communities to each other. 
Principal Component Analysis 
PCA is a method for condensing an abundance of data in a way that captures the essence of the 
original data, while allowing one to interpret a dataset with a lot of dimensions (i.e., multiple 
sample types with varying microbial contents). PCA graphs will flatten complex data into a 2 or 
3-dimensional graph to allow the researcher to visualize differences between the sample sets. 
 Creating PCA plots is a very complex statistical method and it may be overwhelming to 
imagine how the total colony forming units from a variety of bacteria cultured from a single 
specimen are compressed to a single dot on a graph. To better understand this process, I have 
provided a simplified PCA analysis using two periurethral swab specimens (Table 1) plotted as a 
2-dimensional plot (Figure 2). In Figure 2A, it is obvious that most of the dots are spread out 
along a diagonal line and the maximum amount of variation is found between the two endpoints 
of Line 1. Additionally, the dots will be spread out a little above and below the first line, forming 
Line 2. If we rotate the graph (Figure 2), it allows us to visualize left/right and above/below 
variation more easily. What we can conclude is that the data varies a lot on the x-axis from left to 
right (Principal Component 1) and on the y-axis going up and down (Principal Component 2). 
Principal Component 1 is the axis that spans the most variation in the data, while Principal 
munities to each oth r.
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Component 2 is the axis that spans the second most variation in the data. Now, for example, if we 
had 3 different samples, we would have an additional Principal Component 3 and it would span 
the direction of the third most variation. Therefore, there is a principal component for each sample 
and if we collected 200 samples, we would have 200 Principal Components. 
 
Table 1. Total CFU and Influence Scores of Bacteria Cultured from Periurethral Swabs 
 
 
 
 
 
 
 
 
 
 
 
!
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A) 
  
B) 
 
Figure 2. Principal Component Analysis of Two Periurethral Swabs 
 
 
!
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 It is important to note that each dot represents one single sample and does not directly 
plot the bacterial CFU. Due to this, it is important to understand how bacterial CFU is 
incorporated into each plotted specimen. The length and direction of Principal Component 1 is 
determined by the extreme values at each end of the line (i.e., Points A and B, Points D and E). 
These points are then scored on how much they influenced Principal Component 1 using a 
statistical equation (Figure S1). Points close to the ends will have scores further from 0, either 
negative or positive values, because they highly influence PCA 1. Points at opposite sides of the 
line will be scored with similar values, but with opposite signs. Points in the middle will have 
values closer to zero because they have less influence on PCA 1. Similarly, to PCA 1, the 
bacterial CFU are also ranked on how they influence Principle Component 2 and this is repeated 
until all Principle Components are calculated. Now that the influences of PCA 1 and PCA 2 are 
calculated (Figure S1), we can use them to plot the individual samples. For PCA 1 and PCA 2, a 
coordinate of (470500, 222700) and (316600, 278260) were calculated respectively and plotted 
using a scatter plot (Figure 3). Each coordinate pair represents each individual sample and 
combines the total CFU of every unique microbe found in the sample into a single value. It is 
important to note that these 2 data points plot closely together, or cluster, because they are very 
similar to each other both in terms of bacterial diversity and abundance. If we were to use a third 
sample from a different site with much different bacterial diversity and abundance, such as from 
the GIT, we would expect to see 2 clusters. One cluster would contain the two periurethral 
swabs, while the other cluster would contain the single GIT sample. 
 
!
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Figure 3. Scatter Plot Displaying Principal Component Analysis Data 
 
A Brief History of Urine Collection Techniques 
 Two common methods of urine collection include transurethral catheter and clean catch 
collection. Catheter, from the ancient Greek word kathiénai, plainly means “to thrust into” or “to 
send down” and has been used since the time of Egyptian pharaohs, dating back to 1500 BC 
(Feneley et al., 2015). This collection technique was largely used for individuals experiencing 
urinary retention and often included the insertion of bronze tubes, reeds, straws and curled-up palm 
leaves (Feneley et al., 2015). Since its development, this procedure has been modified to 
incorporate aseptic technique but unfortunately still remains relatively invasive. It was not until 
the mid 1950’s that physicians started collecting urine via a non-invasive “clean catch” method 
which was thought to provide a urine sample with the least amount of genital contamination, while 
allowing physicians to treat based on the bacterial findings. Using this method, it was determined 
that 105 colony forming units (CFU) per milliliter (mL) represented the threshold between genital 
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contamination and evidence of pyelonephritis (Kass E. 1956; Kass E.H., 1957). Subsequently, this 
method was adopted for diagnosing bladder infections despite scant evidence that this was 
appropriate (Thomas-White et al., 2016). Furthermore, the 105 CFU/mL is controversial, as several 
researchers have recommended lower thresholds (Lipsky et al., 1987; Stamm et al., 1982; Stark 
and Maki, 1984; Price et al., in preparation). Finally, it is important to consider that the “clean 
catch” protocol was developed before the advent of more sensitive tools, such as deep sequencing 
and EQUC. Relative to EQUC, the standard urine culture method has a 90% false negative 
detection rate for all bacteria and a 50% false negative detection rate for uropathogens. Thus, the 
“clean catch” protocol must be reassessed. First, it must be determined whether a “clean catch” is 
actually possible and, if so, then it is imperative that it be optimized. Combining EQUC with a 
modified “clean catch” collection method would give physicians and researchers a more accurate 
look at the lower urinary tract (LUT) microbiota (i.e., those of the bladder and urethra), while 
allowing collection of urine in a non-invasive and healthy manner. 
How Soap Works 
 The current “clean catch” protocol includes a wipe with Castile soap. Soap molecules are 
composed of a hydrophobic tail and a hydrophilic head. When soap is added to the surface of the 
skin the hydrophobic tails attach themselves to bacteria. Once attached, the soap molecules begin 
to change the bacterium's shape, causing it to lift away from the surface. Eventually, this exposes 
new areas of the bacterium, which allows more soap molecules to attach to these newly exposed 
areas. Eventually, it will form a micelle, which is a spherical structure of soap molecules containing 
the bacterium at the center. Once the micelle is formed, it remains suspended on the surface of the 
skin. It is important to note that micelles are coated with hydrophilic heads that are attracted to 
!
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water. Therefore, with the addition of water, such as when your washing your hands, the 
hydrophilic heads attract to the water and are washed away taking the encapsulated bacteria with 
them and reducing the amount of bacteria present on the surface of the skin. The same would be 
true of a urine stream.  
Alcohol Consumption and the Human Microbiome 
 Alcohol consumption is a normal part of life for many people. Research has shown alcohol 
consumption in moderation can be considered healthy. For example, by drinking just one glass of 
red wine a day (272mL/day), it is possible to modulate your GIT microbiome and attain select 
beneficial microbiota, suggesting a possible prebiotic effect of red wine polyphenols on the GIT 
(Queipo-Ortuno, 2012). In contrast, chronic alcohol consumption can negatively impact the GIT 
(Engen et al., 2015; Mutlu et al., 2012; Purohit et al,. 2008; Queipo-Ortuno et al., 2012) and can 
cause issues such as small intestine bacterial overgrowth, increased intestinal permeability to 
endotoxins, and subsequent liver and organ injury (Bode et al., 1984; Purohit et al,. 2008). With 
as many as 25% of the population regularly engaging in binge drinking every month (Women 
3+/day, Men 4+/day), it is obvious that alcohol may be a contributing factor to various human 
disease states (Center for Behavioral Health Statistics and Quality, 2015). While alcohol 
consumption has been linked to various disorders of the brain, heart, liver, pancreas, and the 
immune system (Center for Behavioral Health Statistics and Quality, 2015), relatively few studies 
have examined the effects on microbial communities outside of the GIT. It is possible that if 
alcohol is able to alter the homeostasis of the GIT microbiome, that it may also influence changes 
to the microbiota of other sites, such as the LUT, and could potentially be an additional factor in 
genitourinary disease.  
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 Alcohol is an organic compound. It refers to ethyl alcohol (i.e., ethanol), which is the 
predominant form of alcohol found in alcoholic beverages (International Alliance for Responsible 
Drinking). The chemical breakdown of alcohol involves the enzymes alcohol dehydrogenase 
(ADH) and aldehyde dehydrogenase (ALDH) (U.S. Department of Health and Human Services, 
2007). ADH breaks down alcohol into acetaldehyde, a known carcinogen, and ALDH can rapidly 
metabolize acetaldehyde further into a less harmful by-product, acetate. On average, acetaldehyde 
exposure from alcoholic beverages is estimated to be around 0.112mg/kg body weight/day and 
significantly increases one’s risk of developing cancer (Lachenmeier et al., 2009). Therefore, 
individuals who participate in episodes of binge drinking (Women 3+/day; Men 4+/day) or chronic 
alcohol abuse (Women 7+/week; Men 14+/week) are exposed to increased levels of acetaldehyde 
and are at greater risk for developing disease (Center for Behavioral Health Statistics and Quality, 
2015). Ethanol and the by-products associated with alcohol consumption (acetaldehyde and 
acetate) have subsequently been measured in the blood and urine of individuals who consumed 
alcohol (Kitazawa et al., 1994; Tsukamoto et al., 1988; Tsukamoto et al., 1993), indicating that 
the body excretes these metabolites into the blood circulation, which is then filtered by the kidneys 
and excreted into the urinary tract. Remarkably, these metabolites remain detectable in the urine 
for at least 8 hours post-alcohol consumption (Tsukamoto et al., 1988; Tsukamoto et al., 1993). 
Interestingly, the work done by Tsukamoto et al. only had participants consume beer, a low alcohol 
content malt beverage, for 20 minutes with a dose between 8-16mL/kg. Even at these very low 
levels of alcohol consumption, they were able to see substantial increases in ethanol, acetaldehyde, 
and acetate. There are no documented studies on the effects of hard liquor on metabolite 
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concentrations in urine. Furthermore, there are no studies that queried the effects of these alcohol 
metabolites on the microbial communities of the urinary tract. 
Alcohol Consumption Effects Bacterial Diversity 
 As stated previously, drinking alcoholic beverages has the ability to modulate your GIT 
microbiome. However, the types of bacteria that thrive depends on the type and amount of 
alcoholic beverages consumed. Therefore, it is possible to modulate one’s GIT microbiome and 
attain select beneficial or non-beneficial microbiota strictly by controlling the type or amount of 
alcoholic beverages consumed (Bode et al., 1984; Miki et al., 2012; Yan et al., 2011; Queipo-
Ortuno et al., 2012).  
 In one study, jejunal aspirates from chronic alcoholics and control patients were collected, 
cultured, and then compared. The researchers found that coliform microorganisms, commonly 
including the genera Citrobacter, Enterobacter, Hafnia, Klebsiella, and Escherichia, were 
cultured 55.6% of the time in alcoholics and only 15.4% of the time in control participants. It was 
hypothesized that the fluctuations in microorganisms may be attributed to functional and 
morphological abnormalities of the jejunum caused by chronic alcohol abuse (Bode et al., 1984). 
 Another study used a mouse model in which one group of mice was given intragastric 
feedings of alcohol and the other was fed an intragastric feeding of an isocaloric diet. Changes in 
microbial diversity was assessed using both conventional culturing techniques and 16s rRNA 
sequencing. The researchers found no changes in microbial diversity following 1 day or 1 week, 
which may be comparable to “binge drinking”. However, intestinal bacteria overgrowth was 
observed in mice that were fed alcohol for 3 weeks compared to controls that received the 
isocaloric diet, which may be comparable to “chronic alcohol abuse”. Alcohol fed mice had a 
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higher predominance of bacteria from the phyla Bacteroidetes and Verrucomicrobia bacteria, 
while control mice had a higher predominance of bacteria from the phylum Firmicutes. They also 
found that these changes in abundance and diversity were associated with the down regulation of 
gene and protein expression, particularly bactericidal c-type lectins including Reg3b and Reg3g 
(Yan et al., 2011). This lectin family is able to shape the commensal and pathogenic bacteria 
present in the gut and it does this by binding lipopolysaccharides found in the outer membrane of 
Gram-negative bacteria (Miki et al., 2012). Therefore, it is clear why the down regulation of these 
lectins would allow increased fluctuations in Gram-negative bacteria, such as Bacteroidetes. 
 Another study found that individuals could regulate gut bacteria by consuming alcohol. 
The following studies focused on wine. Wine is composed of various phenolic compounds 
classified into three distinct categories: non-flavonoids, flavonoids and tannins. Flavonoids have 
been found to have various antimicrobial capabilities. They are potent antioxidants that are capable 
of scavenging free radicals and are metal chelators. They also play a role in reducing the amount 
of inflammation, allergies, arthritis, high blood pressure and even the onset of cancer. One way 
they do this is by manipulating the growth and metabolism of bacteria. All of the wines tested 
showed antimicrobial properties that increased bacterial inhibition as polyphenol concentration 
increased. By testing various polyphenols, they found that multiple pure phenolic compounds and 
polyphenols were able to inhibit bacterial growth, including that of Serratia marcescens, Proteus 
mirabilis, Escherichia coli, Klebsiella pneumonia, and Staphylococcus (Rodriguez Vaquero et al., 
2005), all of which have been known to cause various human disease states. Overall, they found 
that Escherichia coli was the most sensitive bacterium and that Flavobacterium species were 
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resistant to all phenolic compounds tested. This was further shown in a study that followed 
individuals longitudinal before and after the consumption of wine (Table 2). 
 
Table 2. Fluctuations in Gastrointestinal Tract Bacteria in Response to Alcohol 
Enterobacteriaceae Produce Enzymes That Catalyze the Formation of Acetaldehyde 
 A family of bacteria, known as Enterobacteriaceae, include a wide range of Gram-negative 
bacteria mainly found in the guts of humans and animals. Although many are harmless, this family 
of bacteria include genera that contain known pathogens, such as Escherichia, Enterobacter, and 
Klebsiella. These bacteria are facultative anaerobes, which means they are able to ferment sugars, 
such as glucose, to produce lactic acid and acetic acid along with other metabolites. In this group 
of bacteria, E. coli is one of the most heavily studied and is often found to be the causative agent 
of lower urinary tract disorders, such as UTI’s. 
 To better understand its pathogenicity, it is important to assess how E. coli utilizes different 
carbon and nitrogen sources for survival.  The preferred carbon source of E. coli is glucose, which 
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allows it to grow rapidly, while its preferred nitrogen source is ammonia (Bren et al., 2016). When 
pyruvate (a derivative of glucose) is present, an enzyme produced by E. coli, pyruvate: formate-
lyase can cleave the pyruvate into acetyl-CoA and formate. Subsequently, the acetyl-CoA is further 
cleaved into acetate and acetaldehyde. Acetaldehyde can now be reduced even further to ethanol 
(Elmar, 2006).  
 
Figure 4. The Metabolism of Glucose by E. coli 
Two Key Energy Sources for E. coli Can Be Found in the Bladder 
 As previously discussed, E. coli can use both glucose and ammonia as carbon and nitrogen 
sources. Ironically, both of these compounds can be found in urine and are found at higher 
concentrations in patients with different disease states.  
 One example of this is found in individuals with diabetes mellitus. These individuals tend 
to have fluctuations in the amount of glucose present in their blood. Under normal circumstances, 
the convoluted tubules are able to reabsorb glucose fluctuations. However, when blood sugar levels 
rise above a certain threshold (170-200/dL), the capacity of the convoluted tubules is reached and 
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the body rids itself of this excess sugar by excreting it into the urine (Andrianesis and Doupis, 
2013).  
 Increased ammonia concentrations in the urine can be the result of a multitude of disorders. 
Many of these disorders include defective enzymes in the urea cycle, organic acidemias, congenital 
lactic acidosis, fatty acid oxidation defects, and dibasic amino acid transport defects (Chawla 
2013). Similarly, as occurred with diabetes mellitus, when the blood is oversaturated with 
ammonia, it will be excreted into the urine.  
 Currently, diseases such as diabetes mellitus increase the risk for lower urinary tract 
disease. This is mainly thought to be caused by various structural defects along with defective host 
immune factors (Brusche, 2015). However, it is possible that these structural abnormalities 
combined with increased levels of glucose and ammonia in combination may make bladder 
conditions more favorable for pathogenic bacteria, such as E. coli. This may suggest why 
individuals with these disease states have increased risks for UTI’s.  
Roles of Acetaldehyde in Cancer 
 Acetaldehyde, a by-product of ethanol metabolism, is a known carcinogen and increases 
the risk of developing cancers (Lachenmeier et al., 2009), such as those involved in alcoholic liver 
disease. Acetaldehyde is very reactive and combines chemically with cells of the ethanol 
consumer. These chemical combinations form acetaldehyde adducts, which have been shown to 
cause liver damage by triggering immune responses, such as inducing Kupffer cells, TNF- α, 
oxidative stress, and acetaldehyde adduct specific antibodies (IgM, IgG, IgA), which cause auto-
immune attacks on hepatocytes leading to necrosis and fibrosis of the liver (Setshedi et al., 2010). 
Additionally, acetaldehyde may directly interact with DNA, causing small point mutations or large 
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detrimental chromosomal damage, including induction of sister chromatid exchanges. In one 
study, these adducts were combined with cultured hepatic endothelial cells. Upon addition, the 
adducts stimulated the secretion of cytokines and chemokines including TNF- α, Monocyte chemo 
attractant protein-1, and macrophage inflammatory protein-2. Additionally, acetaldehyde adducts 
stimulated the activation of hepatic stellate cells, the cause of scar tissue and liver cirrhosis 
(Setshedi et al., 2010). Overall, acetaldehyde has various mechanisms to cause liver disease. 
 Although acetaldehyde is known to be excreted into the bladder during times of alcohol 
consumption (Kitazawa et al., 1994; Tsukamoto et al., 1988; Tsukamoto et al., 1993), little 
research has been done to study its effects. However, in a case controlled study, they found the 
risk of bladder cancer increased in individuals who always drank compared to individuals who 
never drank (Zaitsu et al., 2016). Additionally, large doses of acetaldehyde were found to stop the 
urine flow and alter the smooth muscles of the bladder (Supniewski, 1927). Due to this, it is 
probable that excessive drinking, as found in individuals with alcohol induced liver diseases, may 
influence bladder disease and may impact the microbiota present. 
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CHAPTER II 
MATERIALS & METHODS 
Patient Recruitment 
 This project was approved by the Loyola University Chicago institutional review board 
(IRB) (LU#208740, LU#209111). All participants gave verbal and written consent for the 
collection and analysis of their periurethral swabs and urine samples for research purposes. 
Participants were either the researchers themselves (Chapter III) or women who regularly 
consumed alcoholic beverages (Chapter III-V). Participants were screened for eligibility with a 
short questionnaire asking how much alcohol the participant consumed on a regular basis (Chapter 
V). 
Periurethral Swab Collection Protocol 
Antiseptic wipes saturated in 2% castile soap, hydrogen peroxide, and water were used to cleanse 
the genital area preceding periurethral swab collection for clinical clean-catch samples only. Wipe 
packages consisted of two wipes. In women, one wipe was used to clean the labia in a front-to-
back wiping motion. The second wipe was used to clean over the urethra. Antiseptic wipes were 
not used preceding modified clean catch protocols. A periurethral specimen was collected using 
an Elution Swab (ESwab) Collection and Transport System. The periurethral swab was collected 
prior to all urine collections to avoid contamination with urine. The ESwab system sustains the 
viability of clinically important aerobes, anaerobes, and fastidious bacteria for up to 48 hours when 
kept between 5-25°C. 
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Voided Urine Collection Protocol 
Initial Stream Urine Collection. 
 Initial stream urine collection involved collecting a voided urine sample into a sterile urine 
cup. The participant placed the sterile urine cup a few inches from the urethra and began urinating 
into the cup until it was half full, at which time the cup was removed. The urine was then 
transferred to a C&S Preservative Plus Urine Tube (Becton Dickinson and Co; Franklin Lakes, 
NJ) containing 2.63mg/mL boric acid, 2.08mg/mL sodium borate, and 1.65mg/mL sodium 
formate, a combination that preserves the urine specimen for up to 48 hours. 4 mL of the remaining 
urine collected in the sterile cup was combined with 10% AssayAssure (Thermo Scientific; 
Waltham, MA) and stored at -80°C for future DNA sequencing. 
Midstream Urine Collection. 
 Midstream urine collection involved collecting a voided urine sample into a sterile urine 
specimen cup. The participant initially urinated into the toilet for about 3-5 seconds before placing 
a sterile urine cup a few inches from the urethra. The participant continued to urinate into the cup 
until it was about half full, at which time the cup was removed. The urine was transferred into a 
C&S Preservative Plus Urine tube (Becton Dickinson and Co; Franklin Lakes, NJ), which 
preserves the urine for up to 48 hours, as previously described. 4mL of the remaining urine 
collected in the sterile cup was combined with 10% AssayAssure (Thermo Scientific; Waltham, 
MA) and stored at -80°C for future sequencing. 
Periurethral Swab Cultivation Protocol 
 Periurethral swab specimens were cultivated using MEQUC (Table 1). MEQUC involved 
plating the periurethral swab specimen using a quantitative pinwheel streak onto Sheep BAP (BD 
!
!
 
21!
21 
BBL™ Prepared Plated Media, Becton Dickinson and 94 Co; Sparks, MD), Columbia-Colistin 
and Nalidicix Acid (CNA) Agar (BD BBL™ Prepared Plated Media), and CDC-Anaerobic Blood 
Agar (BD BBL™ Prepared Plated Media). BAP and CNA Agar were incubated at 37°C in 5% 
CO2 and the CDC-Anaerobic Blood Agar was incubated at 37°C in anaerobic conditions. All plates 
were incubated for 48-72 hours. Following incubation, visibly distinct bacterial colonies were 
counted and recorded. Due to the unpredicted high colony forming units of swab specimens, these 
specimens were initially plated using both 10 µL and 100µL of sample. The plated sample volume, 
either 10µL or 100µL, that could be read clearly without colony overgrowth was used for the 
remainder of that individual’s samples. 
Voided Urine Cultivation Protocol 
 All urine specimens, both initial and midstream, were cultivated using MEQUC (Table 3). 
100µL of the voided urine specimens were plated using a quantitative pinwheel streak onto Sheep 
BAP (BD BBL™ Prepared Plated Media), CNA Agar (BD BBL™ Prepared Plated Media) and 
CDC Anaerobic Blood Agar (BD BBL™ Prepared Plated Media). BAP and CNA Agar were 
incubated at 37°C in 5% CO2 and the CDC-Anaerobic Blood Agar was incubated at 37°C in 
anaerobic conditions. All plates were incubated for 48-72 hours. Following incubation, visibly 
distinct bacterial colonies were counted and recorded.  
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Table 3. Periurethral Swab and Voided Urine MEQUC Protocol 
 
Bacterial and Fungal Isolation, Identification, and Storage 
For each plate, distinct bacterial and/or fungal colonies were counted, documented, sub-cultured 
to new plates and grown as pure cultures. The pure cultures were identified using Matrix-Assisted 
Laser Desorption/Ionization Time of Flight (MALDI-TOF) mass spectrometry. MALDI-TOF is 
an ionization method used to detect, characterize, and quantify biomolecules. This analytical 
technique involves a laser striking a matrix of small organic molecules. The laser energy is 
absorbed by the matrix molecules, which are energetically ablated from the surface of the sample 
carrying the analyte molecules into the gas phase. These ions are then separated based on their 
mass-to-charge ratio to create a mass spectrum. The mass spectrum was compared to a database 
of reference spectra to identify the specific microbe to the species level. Once isolates were 
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identified by MALDI-TOF MS, they were stored in CryoSavers containing Brucella Broth with 
10% glycerol using sterile swabs. Isolates were stored at -80°C until ready for use. 
Recovering Stored Isolates 
Bacterial and/or fungal isolates were removed from -80°C and inoculated onto BAP or CNA plates. 
Plates were incubated for 24-48 hours at 37°C in 5% CO2 or anaerobic conditions depending on 
the isolates preferences. A single colony from the incubated pure agar culture was re-suspended 
into MRS broth, vortexed, then allowed to incubate an additional 24 hours at 37°C in CO2 or 
anaerobic conditions depending on the isolates preferences. 
Ethanol, Acetate, and Acetaldehyde Colorimetric Assays 
Urine collected from participants pre- and post-alcohol consumption was assayed for alcohol 
metabolites (i.e, ethanol, acetaldehyde, and acetate). 100 µL of urine sample from the sterile cup 
was aliquoted into a cryovial and centrifuged for 10 minutes at 13500 rpm to remove any 
particulate.  
Ethanol Assay. 
 To detect ethanol in the urine, I used an Ethanol Assay Kit (Sigma-Aldrich, MAK076). 
The ethanol kit standard dilution was decreased one order of magnitude to extend kit usage. This 
was achieved by diluting 5µL of the 17.15N ethanol standard with 80.87µL of the ethanol assay 
buffer (generating 1 umol/µL standard) followed by the dilution 1µl of the 1umole/µL standard 
solution with 99µL of ethanol assay buffer (generating a 10nmol/µL solution) and finally by 
diluting 10µL of the 10nmole/µL solution with 90µL of ethanol assay buffer to generate a 
1nmole/µL ethanol standard. Urine supernatant (3.33µL) was added to a flat-bottom 96-well plate 
followed by the master reaction mix (46µL ethanol assay buffer, 2µL ethanol probe, 2µL ethanol 
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enzyme mix). Plates were mixed using a horizontal shaker. A standard curve ranging between 0.2-
0.4 nmol/µL was generated using 0, 2, 4, 6, 8, and 10 µL of the 1nmole/µL ethanol standard 
solution in duplicate into a flat-bottom 96-well plate brought up to a final volume of 50µL using 
ethanol assay buffer. Plates were covered tightly and incubated for 60 minutes at room 
temperature. The absorbance was measured at 570nm (A570). If the ethanol values of the urine did 
not fall within linear range of the standard curve, then the urine was diluted using ethanol assay 
buffer and re-tested. All urine samples and standards were run in duplicate.  
Acetaldehyde Assay. 
 To detect acetaldehyde in the urine, an Acetaldehyde Assay Kit (EnzyChrom, EASCT-
100) was used. The acetaldehyde kit standard dilution was lowered from 1.2mM-4mM to 10uM-
60uM to obtain a more accurate standard curve vs sample comparison. The premix was changed 
from 1mL to 200µL working volume to extend kit usage. Briefly, 10µL of urine supernatant was 
added to a flat-bottom 96-well plate and 90µL working reagent (85µL Assay Buffer, 8µL 
NAD/MTT, and 1µL Enzyme A, and 1µL Enzyme B) was added to each urine sample. Sample 
blanks were prepared by combining 10µL pure H2O and Blank Working Reagent (86µL assay 
buffer, 8µL NAD/MTT, and 1µL enzyme B). A standard curve was generated using 10µM, 30µM, 
and 60µM acetaldehyde standards. Plates were mixed using a horizontal shaker, covered tightly 
and incubated for 30 minutes at room temperature. The optical density was measured at 565nm 
and acetaldehyde concentrations were calculated using the obtained standard curve. If the urine 
acetaldehyde values did not fall within linear range of the standard curve, then the urine was diluted 
using pure H20 and re-run. Resulting diluted acetaldehyde concentrations were multiplied by 
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dilution factor to obtain acetaldehyde concentrations. All urine samples, standards, and blanks 
were run in duplicate. 
Acetate Assay. 
 To detect acetate in the urine samples, we used Acetate Assay Kit (Sigma-Aldrich, 
MAK086). The acetate kit standard dilution was proportionally decreased to extend kit usage. This 
was achieved by diluting 1µL of the 100mM acetate stock solution with 99µL of the ethanol assay 
buffer generating a 1mM standard solution. Briefly, 5µL urine supernatant was added to a flat-
bottom 96-well plate and combined with reaction mix (42µL acetate assay buffer, 2µL acetate 
enzyme buffer, 2µL ATP, 2µL Acetate Substrate Mix, 2µL Probe). Plates were mixed using a 
horizontal shaker. A standard curve ranging between 0.04-0.2mM was generated using 0, 2, 4, 6, 
8, and 10 µL of the 1 mM acetate standard solution in duplicate into a flat-bottom 96-well plate 
brought up to a final volume of 50µL using acetate assay buffer. Plates were covered tightly and 
incubated for 40 minutes at room temperature. The absorbance was measured at 450 nm (A450). 
Urine was tested at several dilutions using acetate assay buffer to ensure that the ethanol values 
fell within the linear range of the standard curve. A sample blank (42µL acetate assay buffer, 2µL 
acetate enzyme buffer, 2µL ATP, 2µL Probe) was also set up to remove background signal from 
any ADP or NADH already present in the sample. All urine samples, standards, and blanks were 
run in duplicate. 
2-Fold Broth Micro-Dilutions 
The following dilutions were prepared using bacterial isolates collected pre- and post-binge 
drinking. The isolates subjected to alcohol metabolites were either Lactobacillus crispatus or 
Lactobacillus jensenii; these were the dominant species in the urine sample from which they were 
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isolated. All isolates were subjected to 2-Fold broth micro-dilutions following the same basic setup 
(Figure 5). 
Ethanol Micro-Dilutions. 
100µL of MRS broth was added to wells 2-12 and 200µL of 100% ethanol (17,126mM) was added 
to well 1. 100µL of ethanol was transferred from well 1 into well 2 and mixed by gently pipetting 
up and down to create an 8,563mM ethanol solution. The series of dilutions were continued until 
well 11 was reached and the remaining 100µL from well 11 was discarded. 100µL of the prepared 
bacteria-MRS broth solution was transferred into each well (1-12) and mixed by gently pipetting 
up and down to create ethanol dilutions ranging from 0-8,563mM. Well 12 contained no ethanol 
and was used as a control. 200µL of pure MRS broth was added to well 13 as a sterility control. 
The prepared 96-well plate was incubated for 24 hours. 1:10 serial dilutions were prepared from 
each well to quantify the viable CFU’s at each metabolite concentration for 0 hour, 6 hour, and 24 
hour time points. Growth in each of the wells is expressed relative to that of control well. 
Acetaldehyde Micro-Dilutions. 
99% acetaldehyde was first diluted to 24.75% (4,427mM) using MRS broth. 100µL of MRS broth 
was added to wells 2-12 and 200µL of the 24.75% Acetaldehyde solution was added to well 1. 
100µL of the acetaldehyde dilution was transferred from well 1 into well 2 and mixed by gently 
pipetting up and down to create a 2,213mM acetaldehyde solution. The series of dilutions was 
continued until well 11 was reached and the remaining 100µL from well 11 was discarded. 100µL 
of the prepared bacteria-MRS solution was transferred into each well (1-12) and mixed by gently 
pipetting up and down to create acetaldehyde dilutions ranging from 0-2,213mM. Well 12 contains 
no acetaldehyde and was used as a control. 200µL of pure MRS broth was added to well 13 as a 
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sterility control. The prepared 96-well plate was incubated for 24 hours. 1:10 serial dilutions were 
prepared from each well to quantify the viable CFUs at each metabolite concentration for 0 hour, 
3 hour, 6 hour, and 24 hours time points. Growth in each of the wells is expressed relative to that 
of control well. 
Acetic Acid Micro-Dilutions. 
100% acetic acid was first diluted to 0.0125% (218mM) using MRS broth. 100µL of MRS broth 
was added to wells 2-12 and 200µL of 0.0125% acetic acid solution was added to well 1. 100µL 
of the acetic acid dilution was transferred from well 1 into well 2 and mixed by gently pipetting 
up and down to create a 109mM acetic acid solution. This series of dilutions was continued until 
well 11 was reached and the remaining 100µL from well 11 was discarded. 100µL of the prepared 
bacteria-MRS solution was transferred into each well (1-12) and mixed by gently pipetting up and 
down to create acetic acid dilutions ranging from 0-109mM. Well 12 contained no acetic acid and 
was used as a control. 200µL of pure MRS broth was added to well 13 as a sterility control. The 
prepared 96-well plate was incubated for 24 hours. 1:10 serial dilutions were prepared from each 
well to quantify the viable CFUs at each metabolite concentration for 0 hour, 6 hour, and 24 hour 
time points. Growth in each of the wells is expressed relative to that of control well. 
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Step 1. 
 
Step 2. 
 
Step 3.  
 
 
Figure 5. Protocol for 2-Fold Broth Micro-Dilution 
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Statistical Analysis 
Statistical analysis was prepared using RStudio software version 3.3.2. The Shannon-Wiener Index 
and Simpson’s Index were used to determine differences in biodiversity between the periurethral 
swabs and midstream urines (Chapter III-IV) and are a measure of species evenness and richness, 
respectively. These indices take into account the total number of all unique species present and the 
total CFU/mL of each species. When evenness (Shannon’s) is high, it indicates that all species are 
equally relatively abundant. When evenness is low, it indicates one species dominates. The 
Simpson’s Index measures the chance that two microorganisms drawn at random will be of the 
same species and is a measurement of richness.  The ENS is the number of equally common species 
in a population and it is a measurement of the true diversity between communities. Graphs were 
created using Microsoft Excel for Mac 2016 version 15.19.1, BoxPlotR, and Plotly 2015. 
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CHAPTER III 
ASSESSING THE LONGITUDINAL STABILITY OF THE GENITOURINARY 
MICROBIOTA IN ONE FEMALE 
Introduction 
Microbial communities are longitudinally stable in many human body sites, such as the vagina and 
GIT, and dysbiosis of these communities is a marker of disease (Aagaard et al., 2013; Faith et al., 
2013; “The Human Microbiome Project Consortium”, 2012). Previous researchers have omitted 
studying the stability of the urinary tract, likely due to the clinical dogma that urine is sterile. 
Conversely, emerging evidence shows that urine is not sterile (Wolfe et al., 2012 Fouts et al., 
2012; Brubaker et al., 2014; Hilt et al., 2014; Pearce et al., 2014). Given that urine is not sterile, 
it is imperative to better understand the stability of the LUT microbiota and the associations of 
these microbiota with disease. To help fill this knowledge gap, I surveyed a single asymptomatic 
“healthy” female, collecting daily periurethral swabs and first-void-midstream urines 
longitudinally over a 7-month time period.  Microbes were detected and identified using MEQUC 
and MALDI-TOF mass spectrometry, respectively. 
Longitudinal Study 
Overview and Rationale. 
Other researchers have investigated the stability of the vaginal microbiota (Gajer, et al., 2012).  In 
contrast, no studies have queried the stability of the GUM. Thus, I performed a pilot study to 
characterize the stability of the GUM in one female, hypothesizing that these microbial 
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communities (i.e., those of the periurethra and the LUT) would mimic the genital microbiota and 
remain generally stable. This study consisted of the collection of periurethral swabs followed by 
first void midstream urines from one female over a longitudinal period of 7-months. These 
periurethral swabs and midstream urines were assessed for stability and resilience.  
Results. 
Comparing the Microbiota of Periurethral Swabs to Those of Voided Midstream Urine. All 
samples were collected from a single young healthy female over a 7-month period. The periurethra 
was sampled by periurethral swabs and the LUT was sampled by voided midstream urine. 
Comparisons were made using microbiota profiles, which present the data as the relative 
abundance of each bacterial genus present in each niche. Principal Component Analysis (PCA) 
plots were used to depict variations between the two sites. Principal Component 1 (PC1) reveals 
the largest amount of variation, Principal Component 2 (PC2) captures the second most variation, 
and Principal Component 3 (PC3) shows the third most variation. Statistically, biodiversity was 
calculated using Shannon’s Diversity Index, Simpson’s Index, ENS, and species accumulation 
curves. 
 Over the course of this 7-month period, this female’s individual periurethral microbiota 
differed from her LUT microbiota in terms of total CFU, individual species abundance, diversity 
and especially composition (Figure 6, Table 2, Table 3). 42 unique bacterial species were detected 
in the periurethral swabs; species of the genus Corynebacterium (orange) dominated (>50%) 
53.1% of the swabs, followed by Staphylococcus (14.0%, light blue), Lactobacillus (14%), 
Propionibacterium (10.9%), Enterococcus (6.3%), and Other (1.6%). In contrast, only 23 bacterial 
species were detected in the voided urines; 87.1% of the urines were dominated by the genus 
!
!
 
32!
32 
Lactobacillus (dark blue) followed by Streptococcus (7.1%, green), Staphylococcus (2.9%), and 
Corynebacterium (1.4%). This pattern varied little throughout the 7-month period and shows 
evidence of microbial stability over time. There was little overlap between the two sites, consistent 
with the hypothesis that the microbiota of the periurethral swabs and midstream voided urines are 
distinct. 
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Figure 6. Genus-level Microbiota Profile of One Female’s Periurethral and Voided 
Midstream Urine Over a 7-month Time Period 
Genus-level microbiota composition based on percent CFU/mL (y-axis) for the given collection 
time point (x-axis). The periurethral swabs (above) contain 64 samples.  The urines (bottom) 
contain 70 first void of the day midstream urine samples. Both the periurethral swabs and 
midstream voided urines were collected from the same individual. No antiseptic wipes were used. 
White spaces indicate gaps in collection dates. 
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 PCA analysis confirmed the distinction between the microbiota of the voided urine samples 
(yellow) and the periurethral swabs (blue), as two distinct clusters were observed (Figure 7). The 
periurethral swab microbiota tended to be more diverse, as seen by a wider spread compared to 
the microbiota of the midstream voided urines, which displayed tighter clustering and less 
diversity.  
 
Figure 7. Principal Component Analysis Depicting Associations of Midstream Voided 
Urine and Periurethral Microbiota Over a 7-month Period. 
The factor coefficients are based on genera of bacteria cultured, including Corynebacterium, 
Dermabacter, Enterobacter, Enterococcus, Escherichia, Gemella, Haemophilus, Lactobacillus, 
Micrococcus, Moraxella, Propionibacterium, Staphylococcus, and Streptococcus. This PCA plot 
was calculated by comparing the genus level microbiota profiles, based on relative abundance, of 
midstream voided urines (yellow, n = 70) and periurethral swabs (blue, n = 64) over a 7-month 
period. 
 
  At the species level, the diversity differed greatly between the periurethral swabs and 
midstream voided urines. The voided midstream urine appeared to be less diverse than the 
periurethral swabs, as depicted in the rarefaction curve (Figure 8). This curve graphically displays 
species richness for each group of samples and is plotted temporally. As each curve begins to 
plateau, it indicates total species saturation where it is unlikely any new species will be cultured. 
!
!
 
39!
39 
Rarefaction curves with separate plateaus indicates a difference in species diversity. As mentioned 
previously, the periurethral swabs contained a total of 42 bacterial species and the midstream 
urines contained a total of 24 species. The midstream urine plateaued at a lower value, which 
suggests a lower number of unique species. Statistical analysis supported this claim as follows. 
When comparing the Shannon Diversity Indices (Figure 9A) and Simpson’s Indices (Figure 9B) 
of the periurethral swabs and midstream voided urines, the midstream urine had lower richness 
and higher evenness compared to the periurethral swabs. This indicates that the midstream urine 
is dominated by a single species (Lactobacillus crispatus) with disproportionate abundance. In 
contrast, the periurethral swabs showed higher richness and more evenness when compared to 
midstream urine, which suggests the periurethral swabs are populated by multiple species with 
little dominance. Using ENS, the periurethral swabs were found to be nearly 3 times as diverse 
compared to the voided urines (Figure 9A). 
 
 
Figure 8. Rarefaction Analysis of Periurethral Swabs and Midstream Voided Urines 
The periurethral swabs (n=64) contain 42 unique species and are depicted by a blue line. The 
midstream voided urines (n=70) contain 24 unique species and are depicted by the orange line. 
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A) 
 
B) 
 
Figure 9. Biodiversity of the Periurethral Swabs and Midstream Voided Urine 
(A) Bars depict the Shannon-Wiener Index (H) for the Microbiota of each niche. The orange line 
depicts the Effective Number of Species (ENS) of the microbiota for each cohort. High Shannon’s 
Index suggests multiple species are present with no dominance. Low Shannon’s Index suggests 
that there is likely one dominant species. ENS is the number of equally abundant species that are 
required to acquire the same mean proportional genera abundance. (B) Bars depict the Simpson’s 
Index (D) of the microbiota for each niche. Higher Simpson’s Index suggests that there are multiple 
species present at equal levels. Lower Simpson’s Index suggests that the species present are very 
unequal. 
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Comparison of Clean Catch Voided Urine Over Time. Figure 6 depicts a PCA analysis of the 
98 voided urines from the one female participant. The PCA analysis shows that the microbiota of 
the collected samples became more closely clustered with time. Outliers or samples not closely 
clustered tended to be samples that were collected near the beginning of the study (light teal), 
whereas closely clustered samples tended to be collected near the end of the study (dark teal). This 
evidence supports the hypothesis that improvement in clean catch occurs with practice. This may 
explain why, in Figure 7, the microbiota of some voided samples cluster with those of the swabs. 
 
Figure 10. Principal Component Analysis Depicting the Degree of Association Between 
Midstream Voided Urines Based on Longitudinal Collection Points. 
This PCA plot uses the same factor coefficients as Figure 3 and was calculated by comparing the 
genus level microbiota profiles of 70 midstream voided urines collected longitudinally over a 7-
month period. The color ranges from light to dark teal where lightest indicates novice collection 
techniques and darkest indicates expert collection techniques that were acquired through practice. 
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CHAPTER IV 
REASSESSING CLEAN CATCH 
Introduction 
There is emerging evidence that documents the presence of urinary microbiota in many adult 
women and men (Brubaker et al., 2014; Hilt et al., 2014; Lipsky et al., 1987; Nelson et al., 2010; 
Pearce et al., 2014) and associations between these bacterial populations and various LUT 
disorders have been discovered (Brubaker et al., 2014; Hilt et al., 2014; Lipsky et al., 1987; Pearce 
et al., 2014; Pearce et al., 2015, Thomas-White et al., 2015). Clean-catch, a non-invasive urine 
collection method, is routinely used by physicians for urine cultivation and urinalysis. It is thought 
to provide a urine sample with the least amount of genital contamination, while allowing the 
physicians to treat based on the bacterial findings. Since its development (Smythe et al., 1960), 
more sensitive assays have been advanced for culturing urinary bacteria, whereas the clean catch 
method itself has remained unchanged. In light of these more sensitive assays, I was convinced to 
reassess the protocol, establishing an optimized version of the method.  
Optimizing the clean-catch method is very important. It would prevent physicians from 
erroneously treating urinary disorders based on genital contamination. Also, it would provide 
researchers with an alternative method to invasive procedures, such as catheterized urine 
collection, in exchange for a non-invasive urine collection method that maintains an accurate 
representation of the LUT microbiota. This is particularly important for community-based studies 
or for longitudinal studies that require daily sampling. 
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To assess and optimize the clean-catch method, female volunteers were surveyed by 
collecting periurethral swabs followed by varying types of voided urines. Conditions that could 
alter microbial composition of urine (type of void, time of void and use of antiseptic wipes prior 
to void) were assessed. Microbes were detected using MEQUC. 
Initial vs. Midstream Urine Study 
Overview and Rationale. 
It is important to identify the voided urine specimen, initial or midstream, that provides the least 
amount of genital contamination. The sheer force of urination through the urethra has the ability 
to dislodge urethral bacteria, as well as external genital bacteria, depositing them into the urine 
specimen. Initial stream urine, the first urine to leave the bladder, is hypothesized to contain a 
larger amount of urethral and genital bacteria because it is the first urine to flow through the urethra 
and past the periurethra and thus collects any dislodged bacteria. It is also hypothesized that, by 
collecting midstream urine (i.e., urine collected 3-5 seconds after the onset of urination), most of 
the dislodged bacteria would already be expelled and the urine would contain less urethral and 
genital contamination. It is important to collect a urine sample that represents the LUT opposed to 
the genital tract to avoid false positives due to contamination and to allow accurate interpretation 
of the collected data. The majority of this study consisted of the collection of periurethral swabs 
followed by initial and midstream voided urines from one female. Later, additional participants 
were recruited. To begin, urine specimens were compared to periurethral swabs to determine 
whether initial or midstream urine sampling results in the least amount of genital contamination. 
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Results. 
Initial and Midstream Voided Urines Exhibit Some Resemblance. A total of 79 voided urines 
(9 initial, 70 midstream) were collected from a single healthy female over the course of a 7-month 
time period. All urine specimens were processed using the MEQUC protocol and identified using 
MALDI-TOF mass spectrometry. Figure 11 depicts a PCA comparing initial stream voided urine 
to midstream voided urine samples. All voided urines clustered together, showing that they are 
similar in terms of bacteria detected. However, initial stream urines seemed to form a subcluster 
within the cluster of midstream urines.  
 
Figure 11. Principal Component Analysis Depicting the Degree of Association Between the 
Microbiota in Initial Stream Voided Urines and Midstream Voided Urines. 
The factor coefficients are based on genera of bacteria collected including Corynebacterium, 
Dermabacter, Enterobacter, Enterococcus, Escherichia, Gemella, Haemophilus, Lactobacillus, 
Micrococcus, Moraxella, Propionibacterium, Staphylococcus, and Streptococcus. This PCA plot 
was calculated by comparing the genus level microbiota profiles of initial stream voided urines 
(blue) and midstream voided urines (yellow).  
 
Initial Stream Urines More Closely Resemble Periurethral Swabs. To determine if the 
subclustering of initial stream urines was microbiologically relevant, I focused only on paired urine 
samples and periurethral swabs. A total of 18 voided urines (9 initial, 9 midstream) and 9 
!
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periurethral swabs were collected from a single healthy female over the course of 9 days. As above, 
all urine and periurethral specimens were processed using the MEQUC protocol and identified 
using MALDI-TOF mass spectrometry. Figure 12 compares the microbiota of the initial stream 
urine, midstream urine, and periurethral swabs using radial graphs. Radial graphs depict the 
number of species present using spokes; the length of each spoke represents abundance of that 
bacterial species. The microbiota of the initial stream urine appeared more diverse compared to 
those of the midstream urine, whereas greater overlap of the initial stream urines with the 
periurethral swabs suggests that these two samples are similar.  
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Figure 12. Radar graphs Displaying Bacterial Species Cultured from Periurethral Swabs 
and Voided Urines 
The radar graph consists of radii, called spokes, which represent each bacterial species cultured. 
The CFU for each bacterial species is represented by the length of each spoke. Each spoke is 
connected with a line to create a star-like appearance which allows bacteria from each site to 
cluster. This clustering allows for easy visualization of any overlap between the sites. Samples 1-
9 were collected from one female participant and each represents a single sample collection point. 
Over a 9-day period Periurethral swabs (blue) were collected prior to voided urine collection. Only 
first voids of the day, including initial stream voided urine (green), and midstream voided urine 
(yellow), were collected. 
 
Initial Stream Urines Are More Diverse Than Midstream Urines. The radar graphs suggest 
differences in the diversity of the two different types of voided urines. The Shannon-Wiener Index 
and Simpson’s Index were used to determine differences in biodiversity because they are a measure 
of species evenness and richness, respectively. ENS is the number of equally abundant species that 
are required to acquire the same mean proportional genera abundance. Using these indices, I found 
that the midstream urine had lower richness and lower evenness compared to the initial stream 
urine (Figure 13). This indicates that the midstream urine is dominated by a single species with 
disproportionate abundance. In contrast, the periurethral swabs showed higher richness and higher 
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evenness when compared to midstream urine, which suggests the initial stream urines are 
populated by multiple species with few dominant species. Using ENS, the initial stream urines 
were found to be almost twice as diverse compared to the voided urines (Figure 13a). Taken 
together, the data support the use of midstream urine as the appropriate specimen for collection, 
as microbiologically it least resembles periurethral swabs.  
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A) 
   
B) 
 
Figure 13. Biodiversity of Initial Stream and Midstream Voided Urines 
A) Bars depict the Shannon-Wiener Index (H) for the Microbiota of each urine sample. The red 
line depicts the Effective Number of Species (ENS) of the microbiota for each cohort. (B) Bars 
depict the Simpson’s Index (D) of the microbiota for each urine sample.  
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Antiseptic Wipes Study 
Overview and Rationale. 
Historically, clean catch involves the use of an antiseptic wipe prior to urine collection. Antiseptic 
wipes are saturated in Castile soap and hydrogen peroxide and are thought to eliminate any external 
genital bacteria prior to collection, thereby reducing genital contamination of voided urine 
specimens. However, castile soap is only composed of natural plant based oils and has limited 
bactericidal capabilities. Castile soap, along with other types of soap, can create charged molecules 
that can capture and attach to non-water soluble particles including some bacteria. With the 
addition of water, charged molecules that have already attached to bacteria become free-floating 
and can be rinsed away. Ironically, no water is used during the clean catch wiping process, so it is 
possible that these wipes merely spread and relocate bacteria to other areas of the genitalia. 
Furthermore, it is possible that during urine collection, the urine would act like water and sweep 
these free-floating charged molecules into the urine stream more easily, thereby causing an 
increase in genital contamination. This study consisted of the collection of female periurethral 
swabs followed by the collection of midstream urine with or without the prior use of an antiseptic 
genital wipes in a small cohort of females. Urine specimens were compared to periurethral swabs 
to determine whether wipes or no wipes resulted in the least amount of genital contamination. 
Results. 
Female Participants Have Either Distinct or Non-Distinct Periurethral and Midstream 
Voided Urines. A total of 8 female participants partook in a 17-day study by collecting periurethral 
swabs and first voided midstream urines daily. Urines were cultured using 100µL urine samples, 
whereas periurethral swab specimens were cultured using 10 or 100µL periurethral swab 
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specimens. Thus, the detection limit of urine specimens was 100 CFU/mL and periurethral swabs 
was 1,000 CFU/mL. To accurately identify contamination, females that took part in this study were 
required to have distinct periurethral and urinary microbiota profiles. If their periurethral and 
urinary microbiota profiles were too similar, we were not able to distinguish whether the urinary 
sample represents the LUT or contains vaginal contamination. Alternatively, if the two sites were 
very distinct, we could speculate that the urine sample did not contain vaginal contamination. This 
was achieved by comparing previously collected microbiota profiles (17 periurethral swabs and 
17 voided midstream urines). Of the 8 females that were screened, three had distinctly different 
niches: non-Lactobacillus-dominant periurethral swabs and Lactobacillus-dominant urines 
(Figure 14, A-C). The remaining 5 participants were non-distinct, having Lactobacillus-dominant 
periurethral swabs and midstream voided urines (Fig. 14, D-H).  Only individuals with distinct 
microbiota were analyzed. 
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Figure 14. Genus-level Microbiota Profiles of 8 Female’s Periurethral Swab and 
Midstream Voided Urine 
Genus-level microbiota composition based on percent CFU/mL (1° y-axis) and total CFU (2° y-
axis) for the given collection time point (x-axis). The periurethral swabs (left) and midstream 
voided urines (right) compares the periurethral swabs and midstream voided urines collected at a 
single time point from the same individual. A-C show distinct microbiota profiles and D-H show 
non-distinct microbiota profiles.  
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Antiseptic Wipes Cause a Change in Microbiota Cultured from Midstream Voided Urines 
and Periurethral Swabs. All samples were collected from young healthy females over the course 
of 2 days. Radar graphs (Figure 15) were used to show the bacterial species present in each sample, 
periurethral swabs or voided midstream urine, before and after the use of antiseptic wipes.  
Preceding the use of antiseptic wipes, the microbiota of the periurethral swabs and 
midstream voided urines were clearly distinct. Following the use of antiseptic wipes, changes 
occurred in bacterial abundance and diversity. In most cases, a shift occurred in organisms cultured 
from both the periurethral swabs and urines (Table 6). In each instance, we cultured organisms 
from the urine that were not cultured from the urines prior to use of the antiseptic wipes, but were 
cultured from the swabs (Figure 15, A-C). The diversity of swabs also increased following the 
use of antiseptic wipes in all 4 participants with distinct urine and periurethral microbiota (Table 
6). On average, there were 7.6 unique species cultured from the swabs before wipes and 10.33 
unique species cultured following wipes.  
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(C)  
  
 
Figure 15. Radar Graphs Displaying Bacterial Species Cultured from Periurethral Swabs 
and Voided Midstream Urines from 3 Participants Before and After the Use of Antiseptic 
Wipes. 
The radar graph consists of radii, called spokes, which represent each bacterial species cultured. 
The CFU for each bacterial species is represented by the length of each spoke. Each spoke is 
connected with a line to create a star-like appearance which allows bacteria from each niche to 
cluster. This clustering allows for easy visualization of fluctuations that may occur following the 
use of antiseptic wipes. (A-D) Each represents a single individual. Midstream voided urine 
(yellow) and periurethral swabs (blue) were collected over a 2-day time period. On day 1 (left), no 
wipes were used prior to sample collection. On day 2, (right) antiseptic wipes were used prior to 
sample collection. 
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Table 6. Effects of Antiseptic Wipes on Total Species Cultured from Periurethral Swabs 
and Midstream Voided Urines   
 
Time of Void Study 
Overview and Rationale. 
Due to the variability in an individual’s daily routines, urine specimens may be collected (i.e. 
doctor’s visit) at different times throughout the day. It is important to determine if time of day has 
an impact on the bacteria found in voided midstream urine. Bacteria can replicate exponentially; 
some species double in as little as 20 minutes. Therefore, urines with longer incubation times are 
expected to have a higher CFU/mL than urines with shorter incubation times. This study will 
consist of the collection of midstream voided urine from one female at three different time points 
throughout the day: first void, afternoon void, and last void. The composition of the urine at 
varying time points were compared for changes in bacterial abundance and/or diversity. 
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Results. 
Time of Day Does Not Impact the Bacterial Abundance or Diversity of Midstream Voided 
Urines in One Female. A single healthy female was surveyed over a 7-day period. A total of 21 
midstream voided urines were collected (First void, 7; Mid-day void, 7; Last void, 7). All urine 
specimens were processed using the MEQUC protocol and identified using MALDI-TOF mass 
spectrometry. Figure 16A depicts the total CFU from each time point; I did not observe any 
significant variations in total CFU. Figure 16B depicts the total unique species cultured from each 
time point; I did not see any significant variations in the number of unique species cultured.  
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 (A)  
      
(B) 
      
 
Figure 16. Boxplots Displaying Microbial Characteristics of Midstream Voided Urine 
Based on Time of Day from a Single Female. 
Boxplots display the data as a distribution of the five number summaries (minimum, first quartile, 
median, third quartile, and maximum). The lower cap of the box depicts the first quartile value and 
the upper cap depicts the third quartile value. The single line that dissects the box depicts the 
median value. The whiskers (vertical line ending in a horizontal line) depicts the spread of the 
data. (A) These boxplots show the changes in total CFU cultured from midstream voided urine 
based on time of collection (first void, mid-day void, last void). (B) These boxplots show the 
changes in distinct species cultured from midstream voided urine based on time of collection (first 
void, mid-day void, and last void).
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CHAPTER V 
DETERMINING THE EFFECTS OF ALCOHOL CONSUMPTION  
ON THE GENITOURINARY TRACT 
Introduction  
In several recent studies, it has been shown that the consumption of alcohol has an affect on the 
microbial abundance and diversity of the gastrointestinal tract (GIT) (Engen et al., 2015; Mutlu et 
al., 2012; Purohit et al., 2008; Queipo-Ortuno et al., 2012). However, few studies have focused on 
the affects of alcohol within other human sites that contain microbial communities. There is 
emerging evidence that documents the presence of urinary microbiota in many adult women and 
men. These bacterial populations are found in healthy individuals as well as in individuals with 
various lower urinary tract disorders and diseases (Brubaker et al., 2014; Hilt et al., 2014; Pearce 
et al., 2014; Pearce et al., 2015; Thomas-White et al., 2015). If alcohol is able to alter the 
homeostasis of the GIT microbiome, it may also influence the genitourinary microbiota and could 
potentially be an additional factor in genitourinary disease. 
Defining the Physiological Conditions and Bacterial Composition of Urine           
Pre- and Post-Alcohol Consumption 
Overview and Rationale. 
During our previous studies, we noticed what appeared to be an effect of alcohol consumption on 
the LUT microbiota of one female. The mechanism that caused these changes remained unclear; 
however, it was possible that alcohol by-products were involved. If alcohol plays a role in 
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altering the GUM, we should be able to measure a change either in the microbial composition 
and/or on the physiological conditions of the urine pre- and post-alcohol consumption. Further 
knowledge about the effects of alcohol on human physiology would be beneficial to human health. 
In particular, there may be significant clinical effect for the many people with urinary tract 
disorders. Understanding normal fluctuations of the LUT microbiota, and the impact of 
external/lifestyle factors on the microbial composition, may have significant implications on 
urinary, genital, and sexual health.  
Periurethral swabs and voided midstream urines were collected longitudinally from 8 
female participants who consumed alcohol on a regular basis (≥1/month). Participants kept a daily 
alcohol consumption diary including amount of alcohol consumed, types of alcohol consumed, 
and length of alcohol consumption. To analyze the physiological conditions of urine, a routine 
dipstick was used to measure glucose, bilirubin, ketones, specific gravity, blood, pH, protein, 
urobilinogen, nitrite, and leukocytes. Periurethral swabs and urine were analyzed for microbial 
content by MEQUC. Urinary characteristics, such as microbial contents and physiological 
composition, were compared to alcohol consumption. 
Results. 
There is a Decrease in the Genus Lactobacillus Cultured from Voided Midstream Urines 
Post-Alcohol Consumption. A total of 8 female participants who regularly consumed alcohol 
partook in a 17-day study by collecting periurethral swabs and first voided midstream urines daily. 
Participants kept a daily log, including amount of alcohol consumed, types of alcohol consumed, 
and times of alcohol consumption. Participants were separated based on their dominant urotype 
(i.e. Lactobacillus) (Table 7). Participants were eligible for analysis if they had no alcohol 
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consumption within 3 days prior to an episode of binge of drinking. Additionally, participants were 
required to have distinct periurethral and urinary microbiota profiles. Of the 8 individuals who 
participated, 3 individuals fit these criteria and their data were analyzed.  
Over the course of the study, the periurethral swabs remained relatively stable in terms of 
CFU/mL and distribution of microbes. In contrast, total CFU/mL in midstream voided urine 
decreased drastically following the first day of binge drinking (≥4 alcohol drinks/day). Individuals 
with urotypes L. crispatus (participant’s B and C) and L. jensenii (participant A) were acutely 
influenced by alcohol consumption (Figure 17), as Lactobacillus CFU/mL dropped to zero 
following binge drinking and took 1.33 days to return to baseline. Streptococcus CFU/mL 
remained relatively constant even in the face of binge drinking. These data are consistent with an 
effect of binge drinking on some LUT microbiota of some females, specifically the genus 
Lactobacillus.  
Individuals with non-distinct periurethral and LUT microbiota saw a complete loss of 
Lactobacillus, a partial decrease in Lactobacillus, or no change in Lactobacillus (Figure S3). 
Complete loss of Lactobacillus, as seen in Participant F, suggests that this participant may have 
obtained a clean catch and that the two sites are merely similar. The partial decrease in 
Lactobacillus, such as seen in participant D, may suggest clean catch was not accomplished. This 
less dramatic decrease in “LUT” Lactobacillus could be due to cross contamination with 
periurethral microbiota. There might have been a substantial decrease in urinary Lactobacillus, but 
no effect on the periurethral Lactobacillus; when combined, one would observe a partial decrease. 
No loss in Lactobacillus, such as seen in participant G, may suggest that alcohol does not affect 
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this individual’s urinary Lactobacillus. Alternatively, it may be possible that this individual has 
little Lactobacillus in their LUT and I only captured cross-contamination from the periurethra. 
 
 
Table 7. Lactobacillus Species Cultured from Midstream Voided Urine of Healthy Females. 
All species of Lactobacillus present for each participant are represented by an “x”. Dominant 
urotypes are enclosed by a blue box. Lactobacillus crispatus dominant (B-C, E-F); Lactobacillus 
jensenii dominant (A, D); Lactobacillus gasseri dominant, (H); Co-dominant L. crispatus/L. 
gasseri, (G). 
 
 
 
 
 
 
 
 
 
LACTOBACILLUS IS THE DOMINANT UROTYPE IN 
ALL 8 FEMALES
Participant L.#crispatus L. jensenii L.#gasseri L.#iners L.#vaginalis L.#mucosae
B X
C X
E X X
F X X X X
G X X X
H X X
A X X X
D X X X X
8+f males+ Binge+Drinking 7+females+ 4 females+Distinct+Niches
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Figure 17. Line Graph Depicting Urinary Lactobacillus CFU in Relationship to Binge 
Drinking 
Longitudinal data depicting the relationship between Lactobacillus () and Streptococcus (□) 
from voided midstream urine before and after binge drinking. Participants (A-C) had distinct 
periurethral and voided midstream urines. Data is based on total CFU (y-axis) for a given time 
point (x-axis). Time point 0 illustrates the first morning void following an episode of binge 
drinking. Participant B did not culture Streptococcus from the lower urinary tract. A decrease in 
Lactobacilli CFU is seen following episodes of binge drinking while Streptococcus CFU remains 
stable. 
 
 
 
 
 
 
 
 
 
 
 
 
!
!
 
67!
67 
Measuring the By-Products of Alcohol Metabolism in Urine 
Pre- and Post-Alcohol Consumption 
Overview and Rationale. 
Alcohol metabolites are found in urine post-alcohol consumption (Kitasawa et al., 1994; 
Tsukamoto et al., 1993). These metabolites may have an effect on the resident microbiota of the 
lower urinary tract. 
 To analyze alcohol and its metabolites in the urine, we used colorimetric assays that 
detected ethanol, acetaldehyde, and acetate. Urinary characteristics, such as concentrations of 
alcohol and its metabolites, was compared to alcohol consumption.  
Results. 
Acetaldehyde and Acetate Were Detected in Female Midstream Voided Urine Following the 
Consumption of Alcohol but Ethanol Was Not. The urine of 8 female participants who regularly 
consumed alcohol was tested for alcohol metabolites at various time points over a 17-day period.  
Levels of metabolites were then compared to alcohol consumption using participant’s daily logs. 
The colorimetric kits were able to detect both acetaldehyde and acetate in urine following alcohol 
consumption, but were not able to detect ethanol at any point (Table 8). Acetaldehyde was detected 
in 4 out of 6 individuals who consumed alcohol. Acetate was detected one time and in a participant 
who did not consume alcohol. 
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Table 8. Levels of Alcohol Metabolites Detected in Midstream Voided Urine 
Alcohol metabolites were detected throughout the 17-day study using colorimetric assays. Type 
and concentration of metabolites are as follows: Ethanol (mM), Acetaldehyde (µM), and Acetate 
(mM). Number values indicate assay was performed while dashes indicate assay was not 
completed on that day. The shading of the values is related to alcohol consumption (Red, no 
alcohol consumed; Green, non-binge drinking; Yellow, binge-drinking). 
 
 
 
   A E F D G 
Week  
1 
Friday  
(Day 6) 
Ethanol - - - - - 
Acetaldehyde - - - - - 
Acetate - - - - - 
Saturday 
 (Day 7) 
Ethanol - - - - 0  
Acetaldehyde - - - - 6.83  
Acetate - - - - - 
Sunday  
(Day 8) 
Ethanol - - - - 0  
Acetaldehyde 4.80  8.41  - - 6.28  
Acetate - - - - - 
Week  
2 
Friday  
(Day 13) 
Ethanol - - - - - 
Acetaldehyde - - - - - 
Acetate - - 0  - - 
Saturday  
(Day 14) 
Ethanol - - - - - 
Acetaldehyde - - 44.37  - - 
Acetate  - 0  0  0 0  
Sunday  
(Day 15) 
Ethanol  - - - - - 
Acetaldehyde  - 0  1048.03  0  - 
Acetate  - 0  11.64  0  0  
Monday  
(Day 16) 
Ethanol  - - - - - 
Acetaldehyde  - - - - - 
Acetate  - 0  - 0  0  
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Determining the Affects of Alcohol Metabolites on Bacterial Isolates Cultured  
Pre- and Post-Alcohol Alcohol Consumption 
Overview and Rationale. 
The mechanism that causes a change in bacterial abundance is still unclear; however, it is possible 
that alcohol and its metabolites are involved. This study consisted of exposing urinary isolates 
collected pre- and post- alcohol consumption to varying concentrations of ethanol, acetaldehyde, 
and acetate. To determine sensitivity profiles to various metabolites, the bacteria were quantified 
by using serial dilutions at various metabolite concentrations for varying time points (up to 24 
hours). I predicted urine collected post-alcohol consumption would contain higher concentrations 
of alcohol metabolites as well as microbial isolates that are less sensitive to alcohol metabolites 
compared to urine collected pre-alcohol consumption. 
Results. 
Biological Levels of Ethanol, Acetaldehyde, and Acetic Acid Did Not Affect Viable CFU of 
L. crispatus or L. jensenii Isolates Collected Pre- and Post-Alcohol Consumption. Ethanol and 
acetaldehyde MICs were determined for select isolates. All measured values are listed in Table 9. 
At 24 hours, L. crispatus isolates collected post-alcohol consumption had a greater ethanol 
minimal inhibitory concentration (MIC) compared to isolates collected pre-alcohol consumption 
(Fig. 18, top). L. jensenii isolates collected post-alcohol consumption had a greater acetaldehyde 
MIC at 6 hours compared to isolates collected post-alcohol consumption (Fig. 18b, bottom). 
However, at 24 hours, L. jensenii post-alcohol isolates had lower acetaldehyde MIC compared to 
pre-alcohol isolates (Fig. 18b, bottom). There were no other changes in ethanol, acetaldehyde or 
acetic acid MICs between pre- and post-alcohol isolates. All MICs were significantly above the 
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measured values and literature values of ethanol and acetaldehyde detected in urine. The 
concentrations of acetic acid tested against isolates far exceeded the measured and literature values 
of acetate in the bladder. At the levels we tested, acetic acid MIC was not determined for any of 
the isolates. I conclude that Lactobacillus crispatus and Lactobacillus jensenii isolates were not 
affected by biological levels of ethanol, acetaldehyde, or acetic acid levels found in urine. 
 
(A) 
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(B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
!
!
 
72!
72 
(C) 
 
 
Figure 18.  Minimal Inhibitory Concentrations Curves of Alcohol and its Metabolites for 
Isolates of L. crispatus and L. jensenii Collected Pre- or Post-Alcohol Consumption 
Isolates were subjected to varying concentrations of alcohol metabolites (x-axis). Total CFU for 
each isolate (y-axis) were calculated at separate time points. (A) Minimal inhibitory assays using 
ethanol against L. crispatus (top) and L. jensenii (bottom) comparing isolates collected pre-alcohol 
consumption (left) to post-alcohol consumption (right). (B) Minimal inhibitory assays using 
acetaldehyde against L. crispatus (top) and L. jensenii (bottom) comparing isolates collected pre-
alcohol consumption (left) to post-alcohol consumption (right). (C) Minimal inhibitory assays 
using acetic acid against L. crispatus (top) and L. jensenii (bottom) comparing isolates collected 
pre-alcohol consumption (left) to post-alcohol consumption (right). 
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(A) 
(B) 
 
Table 9. Minimal Inhibitory Concentrations of Alcohol and its Metabolites for isolates of L. 
crispatus and L. jensenii Collected Pre- or Post-Alcohol Consumption 
(A) This table depicts the concentration of alcohol metabolite needed to cause complete inhibition 
of bacterial growth relative to time. Blue boxes indicate changes in MIC between isolates collected 
pre- and post-alcohol consumption. (B) This table indicates the actual concentration of alcohol 
metabolites measured in urine using colorimetric assays and compares those values to recorded 
literature values. 
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CHAPTER VI 
CAPTURING A URINARY TRACT INFECTION 
Introduction 
It is estimated that about 50% of women will develop at least one UTI during their lifetime (Wien 
and Kavossi 2007). Typically, UTIs are diagnosed based on either the presented symptoms of the 
patient or through routine laboratory work ups. UTI symptoms reported by patients may include 
urinary frequency, urgency, dysuria, pelvic pain, incontinence, and hematuria (Wien and Kavossi 
2007). Laboratory work ups, such as standard urine culture (SUC) and routine urine dipsticks, can 
also be used to detect UTIs.  
Detecting an Acute Urinary Tract Infection in a Young Women 
Overview and Rationale. 
The SUC has a limited sensitivity. It is designed to detect relatively large numbers of known 
uropathogens (typically 105 CFU/ml) that grow quickly with limited nutrient requirements in 
ambient atmospheric conditions, especially E. coli (Price et al., 2016). SUC requires 24 hours to 
culture and interpret the results, which delays patient care and ultimately allows for the progression 
of disease. A faster alternative, a routine urine dipstick, may be used to diagnose UTIs, as results 
are available in just a few seconds. Still, the rate of false negatives is substantial, as the dipstick 
misses up to 77% of UTIs from urine culture-positive UTI patients (Mambatta et el 2015). With 
today’s advancing assays, such as MEQUC and colorimetric assays, it may be possible to detect a 
UTI before routine diagnostics. 
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The following information was observed retrospectively from the previously described alcohol 
study (Chapter V). Briefly, the periurethral swabs and voided midstream urines collected over an 
18-day period from a single female participant and were compared. This participant kept a daily 
alcohol consumption diary including amount of alcohol consumed, types of alcohol consumed, 
and length of alcohol consumption. The participant also voluntarily recorded key factors such as 
first day of menses and onset of UTI. To analyze the physiological conditions of urine, a routine 
dipstick was used to measure glucose, bilirubin, ketones, specific gravity, blood, pH, protein, 
urobilinogen, nitrite, and leukocytes. Colorimetric assays were used to analyze ethanol, 
acetaldehyde, and acetate in urine. Periurethral swabs and urine were analyzed for microbial 
content by MEQUC. Urinary characteristics, such as microbial content and metabolite 
composition, were compared to recorded lifestyle factors, such as start of menses and UTI. 
Results.  
The Start of Menses Disrupts the Periurethral and Urinary Microbiota Profiles. 
Microbiota profiles (Figure 19) from both periurethra and urine remained relatively stable for 
Days 1-9. On Day 10, the patient self-reported the onset of menses, which coincided with a change 
in periurethral and urinary microbiota (Figure 19), as well as large amounts of blood detected by 
routine dipstick (Table 10).  
MEQUC Detected E. coli Before Self-Reported UTI. 
MEQUC did not detect E. coli in the urine between days 1-8 (Figure 19). E. coli was first detected 
in the urine on Day 9 (i.e, 9 days before self-reported UTI) and every subsequent day (Table 11). 
MEQUC detected E. coli below the 105 CFU/mL threshold of SUC (Days 9-14). Only on day 15 
did E. coli levels reach that threshold. 
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Routine Dipstick Detected Known UTI Metabolites on the Same Day as Self-Reported UTI. 
Considering known UTI markers (nitrite, leukocytes, blood), the routine dipstick did not detect 
any relevant changes until Day 18 (Table 10). On Day 18, the routine dipstick detected a small 
amount of blood present in the urine, which coincided with the patients self-reported onset of UTI. 
Acetaldehyde and Acetate are Detected in Urine Prior to Self-Reported UTI and Coincide 
with the Presence of E. coli. Acetaldehyde and Acetate were detected using colorimetric assays 
(Table 10) and were only measured on Days 13-15. We saw a rapid increase in acetaldehyde 
starting (Day 14) and the presence of acetate (Day 15), which coincided with an increase in E. coli 
from 700 CFU/mL (Day 13)  to 100,000/mL CFU (Day 15). 
Detected Levels of Acetaldehyde During UTI are Capable of Killing Lactobacillus spp. The 
measured acetaldehyde levels recorded during UTI progression were initially measured at 
44.37µM on day 14 and within 24 hours increased to 1,048.03µM by day 15 (Table 10). When 
comparing acetaldehyde levels to the MIC assays (Fig. 18B), after just 3 hours, L. crispatus had a 
MIC of 553µM and L. jensenii had a MIC of 138µM. However, by 24 hours, L. crispatus had a 
MIC of 138µM and L. jensenii has a MIC of 69µM, which are far below the measured acetaldehyde 
levels. 
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Figure 19. Genus-level Microbiota Profile of One Female’s Periurethral Swab and 
Midstream Voided Urine 
Genus-level microbiota composition based on percent CFU/mL (primary y-axis) for the given 
collection time point (x-axis). The periurethral swabs (above) midstream voided urines (bottom) 
were collected from one female individual. Red asterisk indicates the start of menses and purple 
asterisk indicates self-reported UTI.  
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Table 10. Metabolites Measured in Urine During the Development of a UTI 
This table depicts metabolites measured in the urine from a single individual over the course of 
18-days. Glucose (GLU), Bilirubin (BIL), Ketones (KET), Specific Gravity (SG), Blood (BLO), 
pH, Protein (PRO), Urobilinogen (URO), Nitrite (NIT), and Leukocytes (LEU) were measured 
using a routine urinary dipstick. Acetaldehyde (ALD) and Acetate (ACE) were measured using 
colorimetric assays. Patient self-reported the start of menses (Day 10) and UTI (Day 18). A dash 
(-) indicates specific metabolite a was not tested for that time point. 
 
 
 
Table 11. Changes in E. coli CFU During the Development of a UTI 
This table depicts changes in lower urinary tract E. coli (CFU/mL) from a single individual over 
the course of 18-days. Patient self-reported the start of menses (Day 10) and UTI (Day 18).  
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CHAPTER VII 
DISCUSSION 
 
In Chapter III, the GUM (the periurethral and LUT microbiota) of one healthy female participant 
appear to be generally stable throughout a 7-month period, sustaining a dominant genus with minor 
fluctuations that generally return to baseline within 1-2 days. But what causes those fluctuations? 
Regarding the periurethral microbiota, these fluctuations may be associated with external factors, 
such as sexual activity as seen by Gajer et al. (2012) or the use of antiseptic wipes (Chapter IV). 
The LUT microbiota also experienced extreme fluctuations and these correlated with the use of 
antiseptic wipes use and alcohol consumption, both key factors that were explored in Chapters 
IV and V. Figures 6-9 illustrate that the microbiota of midstream voided urine can be distinctly 
different from those of the periurethral swab, which suggests that clean catch may be acquired 
through voided urine. This suggests that future studies may be able to use midstream voided urine, 
avoiding invasive catheterized urine samples, to accurately sample the female LUT. Additionally, 
clean catch appears to be a learned process (Figure 10). Therefore, simply allowing individuals 
practice may allow for sample collection that avoids the invasive catheter urine sample. This not 
only improves patient care, but is economically favorable.  
 Once I had determined that the GUM can be stable and that a clean catch is possible, I 
sought an optimized method of clean catch urine collection by focusing on additional factors 
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(Chapter IV). I decided to relate the traditional methods of clinical clean catch with a few caveats. 
One important factor of clean catch is the time of collection. It was hypothesized that urine 
collected as the first void of the day would have an increase in bacterial abundance due to the 6-8 
hours of urinary retention as the participant slept.  Surprisingly, I found that the time of collection 
had no impact on the bacterial abundance (Figure 16). This could have important implications on 
the health care field as many physicians see patients throughout the day and this would allow for 
accurate sampling independent of the time of collection. However, the sample size is very small 
and these non-fluctuating conditions may only be observed in this single individual. This 
individual predominately had monoculture samples and it is possible that there could be changes 
in individuals who culture multiple organisms. Other aspects to consider are an individual’s 
hydration habits, diet, and urinary frequency that could change the outcome. For example, if a 
participant consumes heavy amounts of caffeine (diuretics), would we see a change throughout the 
day? Or, if a participant voids every hour, would we see a change between first void of the day 
and afternoon voids? These situations need additional analysis and increasing the number of 
individuals for this study is required to make further conclusions. 
 Clinically, midstream urine has been defined as the “cleanest” type of void. An alternative 
type of void is initial stream urine. By comparing these two voids, it was determined that 
midstream urine less resembled the periurethral swabs (Figure 12). It is important to note that not 
every midstream sample collection resulted in a “cleaner” catch that was distinctly different from 
initial stream. However, midstream urine more often gave a cleaner sample than initial stream 
voids. These findings indicate that midstream urine should remain the preferred sample type. 
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 Collectively, I found that antiseptic wipes tend to increase the diversity of the urine sample, 
specifically increasing the amount of previously cultured periurethral bacteria (Figure 15). The 
periurethral swabs also displayed changes in bacterial diversity. Some bacterial species were 
completely eliminated, whereas others were newly cultured. It is hypothesized that these newly 
cultured organisms may have come from a nearby distinct niche, such as the perineum or deep 
vaginal site, and that the wipes mechanically relocated the bacteria to the area of the periurethra. 
Alternatively, it is possible that some bacteria are merely undetectable prior to wipe use due to low 
CFU and that the total CFU barely passes this threshold the following day. It is important to note 
that during the course of the study, all participants cultured E. coli from their periurethral swabs 
and that wipes tended to relocate genital bacteria to the area of the urethra. Furthermore, if one 
relocates bacteria with motile capabilities (e.g., E. coli or Proteus) to the area of the urethra, they 
are now increasing the chance that these bacteria will travel up the urethra and cause a UTI. This 
finding will have a major impact on the world of clinical practices and research. Removing wipes 
from the clean catch protocol may be advisable to ensure the cleanest urine sample possible and 
to prevent possible self-inoculation and infection.   
 It is important to note the discovery that some females have unique periurethral and urinary 
microbiota profiles, while others do not (Figure 14). While this was not an aspect I initially 
focused on, it quickly became apparent that this must be considered when analyzing current data 
and for future studies. Regarding clean catch, one can determine if clean catch has been acquired 
if one can compare bacteria from the periurethra and urine. Only individuals with distinct 
microbiota profiles can be compared because if the sites are too similar one would not be able to 
determine which bacteria came from which site. 
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 In Chapter V, I assessed the effects of alcohol on the GUM. In a small cohort of females, 
it was found that Lactobacillus was acutely affected by excessive alcohol consumption, while other 
bacteria found in the bladder, such as Streptococcus, remained unaffected. I originally 
hypothesized that alcohol by-products were to blame; however, further analysis revealed this is 
not the case. It is possible that other by-products of alcohol metabolism play a role either directly 
or by triggering other bodily reactions. Lastly, it is already known that alcohol consumption 
triggers immunological responses and it is possible that these immunological factors damage 
bacteria, either directly by targeting specific bacterial species or indirectly by damaging the 
urothelial cells lining the bladder to which bacteria adhere for survival.  
 One participant from the alcohol study developed a UTI (Chapter VI). I was able to 
capture the participant’s baseline GUM and visualize changes that coincided with both 
menstruation and UTI (Figure 19). Interestingly, the changes involved with menses coincided with 
patient’s self-reported menses, but UTI development appeared before the patient’s self report. This 
novel dataset reveals that UTI development can be a gradual process and that the causative agent 
can be detected 10 days prior to patient’s self report and clinical diagnosis. Acetaldehyde 
concentrations in the urine were high enough to inhibit Lactobacillus growth, suggesting this as 
possible mechanism of virulence for E. coli in UTI, because it inhibits protective bacteria, such as 
Lactobacillus, and increases the LUT’s susceptibility to E. coli colonization. It may be of interest 
to develop a rapid acetaldehyde detection kit, such as a urine dipstick, that measures acetaldehyde 
levels in the urine for early UTI detection.  In conclusion, this novel case study provides valuable 
insight into UTI development and it appears that there may be room for improvement in UTI 
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diagnosis, both in early detection and diagnostics used. This also poses the question whether 
feminine hygiene practices (e.g., tampons, pads) play a role in UTI. 
 Collectively, these data give us insight on improving urine collection methods while 
revealing aspects that should be avoided to obtain an accurate sample. Previous work completed 
by Loyola Urinary Education & Research Collaborative (LUEREC) included individuals with pre-
existing urinary disorders who regularly visited the clinic and thus it was possible to obtain a 
catheter urine sample. However, due to the newly established clean catch method, we may be able 
to sample from a larger cohort of individuals found in the public and this would allow us to increase 
our study population to individuals who are not regularly seen in the clinic. Also, these data suggest 
that it may be time to adopt a new optimized method of clean catch as well as new methods for 
detecting UTI.  
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APPENDIX: 
SUPPLEMENTAL FIGURES 
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Figure S1. Calculating PCA Scores 
PCA scores are calculated using the total CFU for each unique bacterial genus or species present 
multiplied by the statistically calculated influence score. The sum of these products is calculated 
to give an individual coordinate. PCA-1 scores will give the x-coordinate, PCA-2 scores will give 
the y-coordinate, and PCA-3 scores (not pictured) will give the z-coordinate. When coordinates 
are combined, a single point can be plotted on a scatter plot. 
 
CFU Influence (CFU*Influence)
Sample212PC12Score: Enterococcus2(A) 0 "14 0
Lactobacillus2(B) 4000 "8 "32000
Escherichia2(C) 6000 0.3 1800
Staphylococcus2(D) 15500 6 93000
Corynebacterium2(E) 19000 12 228000
Enterococcus2(F) 20000 9 180000
Sum 470800
CFU Influence (CFU*Influence)
Sample212PC22Score:2 Enterococcus2(A) 0 "0.2 0
Lactobacillus2(B) 4000 "2 "8000
Escherichia2(C) 6000 12 72000
Staphylococcus2(D) 15500 10 155000
Corynebacterium2(E) 19000 0.3 5700
Enterococcus2(F) 20000 "0.1 "2000
Sum 222700
Sample212Coordinates:2
(470500,/222700)
CFU Influence (CFU*Influence)
Sample222PC12Score: Enterococcus2(A) 3200 "14 "44800
Lactobacillus2(B) 5000 "8 "40000
Escherichia2(C) 10000 0.3 3000
Staphylococcus2(D) 16400 6 98400
Corynebacterium2(E) 19000 12 228000
Enterococcus2(F) 8000 9 72000
Sum 316600
CFU Influence (CFU*Influence)
Sample222PC22Score:2 Enterococcus2(A) 3200 "0.2 "640
Lactobacillus2(B) 5000 "2 "10000
Escherichia2(C) 10000 12 120000
Staphylococcus2(D) 16400 10 164000
Corynebacterium2(E) 19000 0.3 5700
Enterococcus2(F) 8000 "0.1 "800
Sum 278260
Sample222Coordinates:2
(316600,/278260)
!
!
 
86!
86 
 
 
 
(A) 
 
(B) 
 
 
Figure S2. Principal Component Analysis Depicting the Degree of Association Between 
Initial Stream Voided Urines, Midstream Voided Urines, and Periurethral Swabs. 
A total of 79 voided urines (9 initial, 70 midstream) and 64 periurethral swabs were collected from 
a single healthy female over the course of a 7-month time period. The factor coefficients are based 
on genera of bacteria collected including Corynebacterium, Dermabacter, Enterobacter, 
Enterococcus, Escherichia, Gemella, Haemophilus, Lactobacillus, Micrococcus, Moraxella, 
Propionibacterium, Staphylococcus, and Streptococcus. (A) This PCA plot was calculated by 
comparing the genus level microbiota profiles of initial stream voided urine (purple), midstream 
voided urine (yellow), and periurethral swabs (pink). (B) This is a magnified version of PCA plot 
in panel A that eliminates one periurethral outlier. 
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Figure S3. Line Graph Depicting Urinary Lactobacillus CFU in Relationship to Binge 
Drinking 
Longitudinal data depicting the relationship between Lactobacillus from voided midstream urine 
before and after binge drinking. Participants (D, F, G) had non-distinct periurethral and voided 
midstream urines. Data is based on total CFU (y-axis) for a given time point (x-axis). Time point 
0 illustrates the first morning void following an episode of binge drinking.  
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